介细胞干细胞衍生外体miR-143-3p通过Bcl-2/Beclin1通路增强细胞自,减轻糖尿病病
Wenze Song1,2, Jiao Wang2,3,4, Lulu Guan2
1Department of Medical Genetics and Cell Biology, School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang 330031, China.
Biomedicines
|January 28, 2026
概括
骨髓介质干细胞衍生的外体细胞 (BMSC-Exos) 通过传递miR-143-3p以准Bcl-2来增强糖尿病病 (DKD) 的自. 这种机制可以保护小细胞并缓解DKD的进展,强调BMSC-Exos作为一种潜在的无细胞疗法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 糖尿病病 (DKD) 涉及细胞损伤和自功能受损.
- 骨髓介质干细胞衍生的外体细胞 (BMSC-Exos) 对DKD具有治疗前景,但其机制需要阐明.
研究的目的:
- 为了调查BMSC-Exos是否通过miR-143-3p/Bcl-2/Beclin1通路恢复Podocyte自,以延缓DKD的进展.
- 探索BMSC-Exos作为DKD无细胞疗法的潜力.
主要方法:
- 建立了高葡萄糖 (HG) 诱导的小鼠足细胞损伤模型 (MPC5).
- 分析了自蛋白 (Beclin1, Bcl-2, LC3) 和伤害标志物desmin,使用西方污染和免疫光.
- 利用高通量测序来识别BMSC-Exos中的miRNA,并通过双露西法酶试验验验证了miR-143-3p/Bcl-2相互作用.
- 向DKD小鼠注射修改后的BMSC-Exos,以评估治疗效果.
主要成果:
- BMSC-Exos通过上调Beclin1和LC3-II,并降低Bcl-2和desmin的调节来增强Podocytes中的自.
- miR-143-3p在BMSC-Exos中进行了丰富,并直接针对Bcl-2.
- 在DKD小鼠中,BMSC-Exos治疗降低了血糖,尿与肌素的比率 (UACR) 和损伤.
- 抑制miR-143-3p减弱了BMSC-Exos在DKD小鼠中的保护作用.
结论:
- BMSC-Exos提供miR-143-3p来调节Bcl-2/Beclin1轴,促进自和改善DKD.
- 这项研究揭示了BMSC-Exos在自调节中的新机制,支持其作为DKD无细胞疗法的使用.
更多相关视频
08:06Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
Published on: July 2, 2020
5.0K
09:48Large-Scale Preparation of Synovial Fluid Mesenchymal Stem Cell-Derived Exosomes by 3D Bioreactor Culture
Published on: July 26, 2022
5.1K
相关概念视频
01:19Mesenchymal Stem Cells
5.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.6K
00:58Embryonic Stem Cells
32.4K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.4K
01:22Diabetes Mellitus: Type 2 and Gestational
4.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.7K
02:42Transcription Attenuation in Prokaryotes
18.4K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
18.4K
01:25Chronic Kidney Disease I: Introduction
702
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
702
01:24Chronic Kidney Disease II: Clinical Manifestations
617
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
617